Works matching AU Tsuchiya, Masami


Results: 36
    1
    2
    3
    4
    5
    6

    The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study.

    Published in:
    Supportive Care in Cancer, 2024, v. 32, n. 5, p. 1, doi. 10.1007/s00520-024-08498-z
    By:
    • Fujii, Hironori;
    • Tsuchiya, Masami;
    • Watanabe, Daichi;
    • Otsuka, Ryo;
    • Hirate, Daisuke;
    • Takahashi, Katsuyuki;
    • Go, Makiko;
    • Kudo, Toshihiro;
    • Shimomura, Kazuhiro;
    • Ando, Yosuke;
    • Tani, Shinya;
    • Takahashi, Takao;
    • Hayashi, Katsuhisa;
    • Chin, Miki;
    • Matsunami, Naomi;
    • Takahashi, Masaya;
    • Hasegawa, Akiko;
    • Uchida, Takashi;
    • Hashimoto, Hironobu;
    • Kubo, Akiko
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002).

    Published in:
    Journal of Cancer, 2024, v. 15, n. 6, p. 1487, doi. 10.7150/jca.91675
    By:
    • Senri Yamamoto;
    • Masami Tsuchiya;
    • Hirotoshi Iihara;
    • Yoh Hayasaki;
    • Kyoko Hori;
    • Yasuo Kumakura;
    • Daichi Watanabe;
    • Hideki Sakai;
    • Satoshi Nakagawa;
    • Akiko Kudoh;
    • Hajime Oishi;
    • Nobuhiro Kado;
    • Makiko Go;
    • Kota Mashima;
    • Takashi Uchida;
    • Moeka Yasue;
    • Akimitsu Maeda;
    • Kimihiro Nishino;
    • Koji Matsumoto;
    • Shinya Sato
    Publication type:
    Article
    21

    Association between the Co-administration of Histamine H<sub>2</sub> Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis.

    Published in:
    Journal of Cancer, 2022, v. 13, n. 10, p. 3073, doi. 10.7150/jca.73385
    By:
    • Tomoko Yamazaki;
    • Ryuji Uozumi;
    • Hitoshi Kawazoe;
    • Yoshiko Kitazume;
    • Hirotoshi Iihara;
    • Hironori Fujii;
    • Masaya Takahashi;
    • Takahiro Arai;
    • Yasushi Murachi;
    • Yumiko Sato;
    • Takahiro Mikami;
    • Koji Hashiguchi;
    • Tomoe Yoshizawa;
    • Katsuyuki Takahashi;
    • Yukiyoshi Fujita;
    • Yuki Hosokawa;
    • Issei Morozumi;
    • Masami Tsuchiya;
    • Atsushi Yokoyama;
    • Hironobu Hashimoto
    Publication type:
    Article
    22

    Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10008-2
    By:
    • Kitazume, Yoshiko;
    • Kawazoe, Hitoshi;
    • Uozumi, Ryuji;
    • Yoshizawa, Tomoe;
    • Iihara, Hirotoshi;
    • Fujii, Hironori;
    • Takahashi, Masaya;
    • Arai, Takahiro;
    • Murachi, Yasushi;
    • Sato, Yumiko;
    • Mikami, Takahiro;
    • Hashiguchi, Koji;
    • Yamazaki, Tomoko;
    • Takahashi, Katsuyuki;
    • Fujita, Yukiyoshi;
    • Hosokawa, Yuki;
    • Morozumi, Issei;
    • Tsuchiya, Masami;
    • Yokoyama, Atsushi;
    • Hashimoto, Hironobu
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.

    Published in:
    Oncologist, 2024, v. 29, n. 6, p. e741, doi. 10.1093/oncolo/oyae015
    By:
    • Takahashi, Kaori;
    • Uozumi, Ryuji;
    • Mukohara, Toru;
    • Hayashida, Tetsu;
    • Iwabe, Midori;
    • Iihara, Hirotoshi;
    • Kusuhara-Mamishin, Kanako;
    • Kitagawa, Yuko;
    • Tsuchiya, Masami;
    • Kitahora, Mika;
    • Nagayama, Aiko;
    • Kosaka, Shinkichi;
    • Asano-Niwa, Yoshimi;
    • Seki, Tomoko;
    • Ohnuki, Koji;
    • Suzuki, Akio;
    • Ono, Fumiko;
    • Futamura, Manabu;
    • Kawazoe, Hitoshi;
    • Nakamura, Tomonori
    Publication type:
    Article
    31
    32
    33
    34
    35
    36